Hypovolemic Shock — A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
Citation(s)
A Prospective, Multi-centric, Open-labeled, Phase-IV Study to Assess Safety and Efficacy of LYFAQUIN™ (Centhaquine Citrate) as a Resuscitative Agent for Hypovolemic Shock to be Used as an Adjuvant to Standard Treatment of Shock